Valsartan-hctz 80-12.5 MG tab 90S
Ended Awarded
- Contract number
- SPE2DR26F8YVL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,388
Award facts
- Contract value 100% obligated
- $3,388.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,388.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 80-12.5 mg tablets (90-count supply) with an ultimate completion date of November 3, 2025. This non-set-aside competitive award was issued on October 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider supporting the Defense Health Agency and other federal military and veteran healthcare systems. The parent IDC contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This specific delivery order represents one of numerous pharmaceutical procurements AmerisourceBergen fulfills through its federal contract portfolio, which spans medications for various therapeutic areas including endocrinology, neurology, pain management, and infectious disease treatment, demonstrating the vendor's extensive capability to meet diverse federal medical supply requirements through competitive federal procurement channels.
Quick answers
Who was awarded contract SPE2DR26F8YVL?
SPE2DR26F8YVL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26F8YVL worth?
The government has obligated $3,388 on SPE2DR26F8YVL.
Is contract SPE2DR26F8YVL an order under another contract?
Yes. SPE2DR26F8YVL is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YVL competed?
The extent of competition for SPE2DR26F8YVL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award